doctor gently injecting treatment into the knee
Hymovis

Content prepared by Direct Doctor Supply’s Editorial team.


Last Updated On September 25, 2026

Hymovis Injection Ingredients – About HYADD4

Nov 21, 2024

Hyaluronic acid (HA) is a naturally occurring substance in the body that lubricates and cushions joints. Recent studies show that HA injections can effectively treat osteoarthritis by relieving pain and improving joint function.

Hymovis is an advanced injectable treatment for knee osteoarthritis. It utilizes HYADD®4, a unique, highly viscoelastic form of hyaluronic acid, to provide prolonged relief and improve joint mobility.

In this article, we explore the Hymovis injection ingredients, focusing on HYADD®4, to understand how it supports joint health and pain management.

Key Takeaways

  • Hymovis injections use HYADD®4, a modified high-molecular-weight hyaluronic acid, to deliver superior joint lubrication and cushioning.
  • HYADD®4 reduces pain, improves joint mobility, and supports cartilage regeneration, addressing both symptoms and underlying joint health.
  • Its resistance to breakdown ensures durability, offering relief for up to six months with just two injections.
  • Hymovis is generally well tolerated, with only mild, temporary side effects such as swelling or redness at the injection site.
HYMOVIS 01
HYMOVIS® (German)

$ 629.00
Add To Cart
–+
NEOPHARMED SUPARTZ ITALIAN 5X2.5ML 01
SUPARTZ® (Italian)

$ 319.00
Add To Cart
–+

About: Trusted by over 2,000+ global clients since 2014, Direct Doctor Supply has become a leading supplier of cosmetic, skincare, and orthopedic products for medical and aesthetic professionals. Direct Doctor Supply offers a wide range of authentic brand-name products at competitive wholesale prices, sourced from around the world.

What is HYADD4?

HYADD®4 is the key component of Hymovis injections, a modified form of hyaluronic acid (HA) designed to provide superior joint lubrication and cushioning for individuals with knee osteoarthritis. Unlike standard HA, HYADD®4 is a high-molecular-weight, viscoelastic compound with unique properties that enhance its efficacy.

checking knee via ultrasound

The molecular structure of HYADD®4 incorporates advanced crosslinking technology, which makes it more resistant to degradation within the joint. This durability helps it stay effective longer than traditional hyaluronic acid formulations, supporting longer-lasting joint lubrication and reduced pain. Its high viscosity and elasticity mimic the natural synovial fluid, restoring smooth movement and protecting the cartilage from wear and tear.

For healthcare professionals, clinics, and eligible buyers looking to buy Hymovis online, Direct Doctor Supply offers access to Hymovis and other medical products for clinical use.

How Hymovis Injection Ingredients Work Against Osteoarthritis

Hymovis injections leverage the unique properties of HYADD®4 to address joint issues caused by osteoarthritis. Its advanced formulation closely replicates the natural components of healthy synovial fluid, ensuring optimal lubrication and shock absorption.

administering knee injection to treat osteoarthritis

What sets HYADD®4 apart is its resilience within the joint environment. It enhances joint mechanics by reducing wear and tear on cartilage and mitigating friction between bone surfaces. This protective action not only reduces pain but also supports the long-term health of the joint. Additionally, HYADD®4’s extended duration of action means patients need fewer injections, making it a convenient option for those seeking sustainable relief.

2025 Study Update: HA May Benefit Less Advanced Knee OA

A 2025 systematic review evaluated randomized controlled trials investigating intra-articular hyaluronic acid injections for knee osteoarthritis. The researchers examined factors that may influence treatment outcomes, including patient characteristics and the molecular weight of the HA formulation. The findings suggested that intra-articular HA may be particularly beneficial for patients with less advanced knee osteoarthritis, providing additional context for selecting appropriate candidates for viscosupplementation.[

Benefits of HYADD4 in Hymovis Treatment

Including HYADD®4 in Hymovis injections offers several distinct benefits for managing knee osteoarthritis [1]. The Hymovis injection ingredients, particularly HYADD®4, are formulated to support joint lubrication, cushioning, and mobility:

exercising the knee
  • Effective Pain and Swelling Reduction: HYADD®4 enhances joint lubrication and reduces friction, relieving discomfort and swelling often associated with osteoarthritis.
  • Enhanced Mobility and Joint Function: As a lubricant and shock absorber, HYADD®4 supports smoother joint movement and helps patients regain flexibility in their knees.
  • Cartilage Support and Repair: Unlike some treatments, HYADD®4 promotes cartilage regeneration, aiding in tissue repair and fostering healthier, more durable cartilage.
  • Long-Lasting Relief: Patients benefit from fewer injections compared to other hyaluronic acid treatments, with relief lasting several months.
  • Proven Safety Profile: Hymovis injections are generally safe, with only mild and temporary side effects like swelling or redness at the injection site.

The Scientific Basis for HYADD4’s Effectiveness

HYADD4’s effectiveness in Hymovis injections is grounded in its unique molecular structure and its ability to mimic the natural properties of synovial fluid.[2] Studies show that HYADD4 forms a stable hydrogel when injected into the joint, lubricating and protecting it.

  • biz..: “I love it! I was getting another injection every six months. Hymovis has been working very well for me. Now I get Hymovis every 12 months.”

Additionally, a multi-centre, open label, long-term follow-up study evaluated the benefits of Hymovis in treating knee osteoarthritis. The study found that two intra-articular injections of Hymovis significantly reduced pain and improved joint function over a period of 52 weeks

  • Anonymous: “I am a 72-year-old woman and recently had my 3rd set of Hymovis shots in my right knee. Had first shots in June of 2021, second in Nov. 2021, and third June 2022. After the first set was given in June 2021, it took about 2 weeks for me to get relief. But since then, I have been virtually pain-free. I had tried physical therapy – no good. Had arthroscopic surgery to remove meniscus – no good. Before knee replacement, my doctor recommended Hymovis shots – and I’m so glad he did! They work for me.”

Furthermore, the MOKHA Study explored the biological and structural effects of Hyadd4 on osteoarthritic knees, finding increased cartilage volume and Type II collagen turnover. These findings highlight Hyadd4’s potential structural benefits, making it a promising non-surgical treatment option for osteoarthritis.

Understanding the Durability of HYADD4 Treatment

Unlike traditional hyaluronic acid formulations, HYADD®4 is chemically modified to resist breakdown within the joint. This means it remains effective longer, often providing relief from knee osteoarthritis symptoms for up to six months or more.

When comparing Hymovis vs Hyalgan, the durability of HYADD®4 sets Hymovis apart. Hyalgan, while effective, uses low-molecular-weight hyaluronic acid, which may require more frequent injections to maintain results. In contrast, the advanced crosslinked structure of HYADD®4 allows for sustained joint lubrication and cushioning with just two injections, making it a convenient and long-lasting solution for patients.

This enhanced durability not only reduces the need for repeated treatments but also helps patients maintain improved mobility and reduced pain over extended periods.

Conclusion

Hymovis injections, powered by HYADD®4, are an effective solution for managing knee osteoarthritis. Understanding the Hymovis injection ingredients, particularly HYADD®4, helps explain how the treatment supports joint lubrication, cushioning, and mobility. Acting as a cushion within the joint, Hymovis can help enhance movement and reduce discomfort while supporting overall joint health.

With its innovative formula and long-lasting relief, Hymovis stands out as an excellent choice for individuals seeking improved knee function and a better quality of life.

FAQs

1. What makes Hymovis different from other hyaluronic acid injections?

Hymovis uses HYADD®4, a unique, high-molecular-weight hyaluronic acid that provides enhanced lubrication and longer-lasting relief compared to standard formulations.

2. How long do the effects of Hymovis last?

Most patients experience relief for up to six months after completing the two-injection regimen.

3. How does Hymovis promote cartilage regeneration?

HYADD®4 in Hymovis stimulates cartilage repair by reducing friction and encouraging the production of natural hyaluronic acid, supporting joint health over time.

4. Who is a suitable candidate for Hymovis injections?

Patients with knee osteoarthritis who have not responded well to other treatments, such as physical therapy or oral medications, may benefit from Hymovis injections. Consult a healthcare provider to determine suitability.

Need help, additional info, or customized deals?

Talk with our sales representative.

Book a Meeting

Citations

[1] Bernetti, Andrea, et al. “New Viscoelastic Hydrogel Hymovis MO.RE. Single Intra-Articular Injection for the Treatment of Knee Osteoarthritis in Sportsmen: Safety and Efficacy Study Results.” Frontiers in Pharmacology, vol. 12, Frontiers Media SA, May 2021. doi:10.3389/fphar.2021.673988.

[2] “A Multi-Centre, Open Label, Long-Term Follow-Up Study to Evaluate the Benefits of a New Viscoelastic Hydrogel (Hymovis®) in the Treatment of Knee Osteoarthritis.” European Review, 15 Mar. 2016. https://www.europeanreview.org/article/10445. Accessed 25 Sept. 2026.

[3] Hyaluronan V. High Molecular Weight. https://hcp.hymovis.com/wp-content/uploads/sites/2/2023/02/Hymovis-Package-Insert-USA-68573-13-C-June-20211.pdf.

[4] Sendić, G. Knee Joint. Kenhub, 3 Mar. 2022.

[5] Migliorini, Filippo, et al. “Intra-Articular Hyaluronic Acid Injections May Be Beneficial in Patients with Less Advanced Knee Osteoarthritis: A Systematic Review of Randomised Controlled Trials.” Sports Medicine (Auckland, N.Z.), Feb. 2025, pp. 10.1007/s40279-025-02265-8. doi:10.1007/s40279-025-02265-8. Accessed 25 Sept. 2026.

Sourcing and accuracy for this article follow our Editorial policy: claims are cross-checked against clinical literature, regulatory filings, and manufacturer specifications before anything is published